Hi,
moomoo ID:NaN
Log Out
English
Back
Download
Log in to access Online Inquiry
Quotes
Detailed Quotes
Company Overview
Company ProfileCompany Executives
Financial Analysis
Main CompositionKey IndicatorsFinancial Statement
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > GLUE Monte Rosa Therapeutics > Detailed Quotes

GLUE Monte Rosa Therapeutics

Watchlist
8.210
+1.080+15.15%
Close  02/03 16:00 ET
8.000
-0.210-2.56%
Post Mkt Price 02/03 16:43 ET
High
8.500
Open
7.150
Turnover
1.78M
Low
7.150
Pre Close
7.130
Volume
220.42K
Market Cap
397.36M
P/E(TTM)
Loss
52wk High
15.540
Shares
48.40M
P/E(Static)
Loss
52wk Low
6.050
Float Cap
205.35M
Bid/Ask %
-81.82%
Historical High
45.560
Shs Float
25.01M
Volume Ratio
0.51
Historical Low
6.050
Dividend TTM
--
Div Yield TTM
--
P/B
1.37
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.88%
Amplitude
18.93%
Avg Price
8.097
Lot Size
1
Float Cap
205.35M
Bid/Ask %
-81.82%
Historical High
45.560
Shs Float
25.01M
Volume Ratio
0.51
Historical Low
6.050
Dividend TTM
--
P/B
1.37
Dividend LFY
--
Turnover Ratio
0.88%
Amplitude
18.93%
Avg Price
8.097
Lot Size
1
Post-Market
5D
1D
1W
1M
1Q
1Y
Price Forecast

News

Comment

News

Announcement

Company Overview More
Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.
CEO： Mr. Markus Warmuth
Market： NASDAQ
Listing Date： 06/24/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Get Started
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist